ASLAN Pharmaceuticals Limited (ASLN:NASDAQ) soared at $5.2, representing a gain of 36.1%. On Fri 29 Nov 19, ASLN:NASDAQ hit a New 2-Week High of $3.82. The stock got featured on our News Catalysts scanner on Mon 02 Dec 19 at 03:32 PM in the 'PUBLIC OFFERING' category. From Fri 08 Nov 19, the stock recorded 50.00% Up Days and 40.00% Green Days
The stock spiked on Fri 29 Nov 19 at $7.07 with a volume of 14M+.
About ASLAN Pharmaceuticals Limited (ASLN:NASDAQ)
ASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies.
Top 10 Gainers:
- Kodiak Sciences Inc. (KOD:NASDAQ), 72.47%
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 56.33%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 44.22%
- Yield10 Bioscience, Inc. (YTEN:NASDAQ), 41.09%
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 36.13%
- Oramed Pharmaceuticals Inc. (ORMP:NASDAQ), 29.71%
- Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ), 29.33%
- NF Energy Saving Corporation (BIMI:NASDAQ), 28.9%
- SAExploration Holdings, Inc. (SAEX:NASDAQ), 28.57%
- Hexindai Inc. (HX:NASDAQ), 26.88%